| Literature DB >> 29018425 |
Wen Xiong1, Wei Zhang1, Wenjuan Yuan1, Hongxu Du1, Ke Ming1, Fangke Yao1, Jingying Bai1, Yun Chen1, Jiaguo Liu1, Deyun Wang1, Yuanliang Hu1, Yi Wu1.
Abstract
The duck virus hepatitis (DVH) caused by the duck hepatitis virus A (DHAV) has produced extensive economic losses to the duck industry. The currently licensed commercial vaccine has shown some defects and does not completely prevent the DVH. Accordingly, a new alternative treatment for this disease is urgently needed. Previous studies have shown that icariin (ICA) and its phosphorylated derivative (pICA) possessed good anti-DHAV effects through direct and indirect antiviral pathways, such as antioxidative stress. But the antioxidant activity showed some differences between ICA and pICA. The aim of this study is to prove that ICA and pICA attenuate oxidative stress caused by DHAV in vitro and in vivo, and to investigate their mechanism of action to explain their differences in antioxidant activities. In vivo, the dynamic deaths, oxidative evaluation indexes and hepatic pathological change scores were detected. When was added the hinokitiol which showed the pro-oxidative effect as an intervention method, pICA still possessed more treatment effect than ICA. The strong correlation between mortality and oxidative stress proves that ICA and pICA alleviate oxidative stress caused by DHAV. This was also demonstrated by the addition of hydrogen peroxide (H2O2) as an intervention method in vitro. pICA can be more effective than ICA to improve duck embryonic hepatocytes (DEHs) viability and reduce the virulence of DHAV. The strong correlation between TCID50 and oxidative stress demonstrates that ICA and pICA can achieve anti-DHAV effects by inhibiting oxidative stress. In addition, the superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) of ICA and pICA showed significant difference. pICA could significantly inhibit the phosphorylation of p38, extra cellular signal regulated Kinase (ERK 1/2) and c-Jun N-terminal kinase (JNK), which were related to mitogen-activated protein kinases (MAPKs) signaling pathways. Ultimately, compared to ICA, pICA exhibited more antioxidant activity that could regulate oxidative stress-related indicators, and inhibited the phosphorylation of MAPKs signaling pathway.Entities:
Keywords: duck hepatitis virus A; icariin; mitogen-activated protein kinases signaling pathways; oxidative stress; phosphorylated modification
Year: 2017 PMID: 29018425 PMCID: PMC5622922 DOI: 10.3389/fmicb.2017.01850
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
The clinical curative effect of ICA and pICA in intervention experiment.
| Group | Samples (feathers) | Final deaths (feathers) | Mortality rate (%) |
|---|---|---|---|
| BC | 45 | 0 | 0.0a |
| HK | 45 | 0 | 0.0a |
| VC | 45 | 36 | 80.0d |
| VC-i | 45 | 41 | 91.1d |
| ICA | 45 | 29 | 64.4c |
| ICA-i | 45 | 28 | 62.2c |
| pICA | 45 | 23 | 51.1b |
| pICA-i | 45 | 28 | 62.2c |
Pearson’s correlation coefficients between mortality rate and oxidative stress index.
| Mortality rate | GSH-PX | SOD | MDA | CAT | |
|---|---|---|---|---|---|
| Mortality rate | 1 | -0.544 | -0.743 | 0.896∗ | -0.809 |
| GSH-PX | 1 | 0.867∗ | -0.772 | 0.305 | |
| SOD | 1 | -0.905∗ | 0.306 | ||
| MDA | 1 | -0.574 | |||
| CAT | 1 |
H2O2 effective concentration in DEHs.
| Concentration (μmol/mL) | Cell viability (% of control) | |||
|---|---|---|---|---|
| 2 h | 4 h | 2 h | 4 h | |
| 125.000 | 0.074 ± 0.003e | 0.120 ± 0.002f | 11.4 | 15.3 |
| 62.500 | 0.076 ± 0.003e | 0.126 ± 0.002f | 11.7 | 16.0 |
| 31.250 | 0.069 ± 0.002e | 0.130 ± 0.003f | 10.7 | 16.7 |
| 15.625 | 0.074 ± 0.004e | 0.119 ± 0.003f | 11.3 | 15.2 |
| 7.813 | 0.079 ± 0.003e | 0.152 ± 0.003f | 12.2 | 19.5 |
| 3.906 | 0.137 ± 0.003d | 0.216 ± 0.006d | 21.1 | 27.6 |
| 1.953 | 0.332 ± 0.002c | 0.462 ± 0.013c | 51.4 | 59.1 |
| 0.977 | 0.572 ± 0.004b | 0.669 ± 0.011b | 88.4 | 85.8 |
| 0.488 | 0.654 ± 0.011a | 0.789 ± 0.007a | 101.1 | 101.1 |
| CC | 0.646 ± 0.003a | 0.031 ± 0.012a | ||
Evaluation indices of oxidative in vitro.
| Index | BC | VC | ICA | pICA |
|---|---|---|---|---|
| SOD (U/mgport) | 50.025 ± 0.376c | 36.316 ± 0.738d | 53.204 ± 0.269b | 55.339 ± 0.570a |
| MDA (nmol/mgprot) | 9.668 ± 0.731b | 12.053 ± 0.950a | 4.198 ± 0.658c | 3.833 ± 0.316c |
| NOS (U/mgprot) | 22.145 ± 0.192b | 25.923 ± 0.712a | 23.922 ± 0.747ab | 23.695 ± 0.840ab |
| CAT (U/mgprot) | 20.224 ± 0.336a | 18.555 ± 0.224b | 20.667 ± 0.495a | 19.998 ± 0.382a |
| GSH (μmol/L) | 8.885 ± 0.884a | 2.435 ± 0.217c | 5.006 + 0.513b | 6.636 ± 0.801b |
| GSH-PX (U/mgprot) | 110.903 ± 2.205c | 75.298 ± 1.275d | 125.013 ± 1.267b | 142.872 ± 3.378a |
Pearson’s correlation coefficients between TCID50 and oxidative stress.
| TCID50 | GSH-PX | SOD | GSH | MDA | CAT | |
|---|---|---|---|---|---|---|
| TCID50 | 1 | -0.674 | -0.780 | -0.567 | 0.818 | -0.967 |
| GSH-PX | 1 | 0.988 | 0.991 | -0.976 | 0.840 | |
| SOD | 1 | 0.958 | -0.998∗ | 0.914 | ||
| GSH | 1 | -0.937 | 0.758 | |||
| MDA | 1 | -0.938 | ||||
| CAT | 1 |